Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company manufactures and sells pharmaceutical products.
Cipla Limited, also popularly known as Cipla, is a listed public company incorporated on 17 August, 1935. It is classified as a public limited company and is located in , . It's authorized share capital is INR 175.00 cr and the total paid-up capital is INR 161.54 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Prathivadibhayankara Rajagopalan Ramesh | 01915274 | 4 years |
Director | Mandar Purushottam Vaidya | 09690327 | 3 years |
Director | Yusuf Khwaja Hamied
Shareholder
|
00029049 | 53 years |
Director | Adil Zainulbhai | 06646490 | 11 years |
Managing Director | Umang Vohra
Shareholder
|
02296740 | 9 years |
Director | Robert Stewart | 03515778 | 4 years |
Director | Kamil Hamied | 00024292 | 1 years |
Director | Maya Hari | 01123969 | 1 years |
Director | Abhijit Jagdish Joshi | 07115673 | 1 years |
Director | Sharmila Nitin Paranjpe | 02328770 | 1 years |
Director | Balram Bhargava | 10479707 | 1 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
The Cipla Empowerment Trust | South Africa | - | - |
Cipla Health Employees Stock Option Trust | India | - | - |
Aspergen Inc | United States | - | - |
Mirren (Pty) Limited | South Africa | - | - |
Medpro Pharmaceutica (Pty) Limited | South Africa | - | - |
Cipla Select (Pty) Limited | South Africa | - | - |
Cipla Medpro Botswana (Pty) Limited | Botswana | - | - |
Cipla-Medpro Distribution Centre (Pty) Limited | South Africa | - | - |
Cipla-Medpro (Pty) Limited | South Africa | - | - |
Cipla Medpro Manufacturing (Pty) Limited | South Africa | - | - |
Cipla Dibcare (Pty) Limited | South Africa | - | - |
Cipla Therapeutics Inc | United States | - | - |
Cipla Kenya Limited | Kenya | - | - |
Madison Pharmaceuticals Inc. | United States | - | - |
Cipla Technologies LLC | United States | - | - |
Exelan Pharmaceuticals Inc. | United States | - | - |
InvaGen Pharmaceuticals Inc. | United States | - | - |
Cipla USA Inc. | United States | - | - |
Cipla (China) Pharmaceutical Co., Limited | China | - | - |
Cipla (Jiangsu) Pharmaceutical Co., Limited | China | - | - |
Cipla Colombia SAS | Colombia | - | - |
Cipla Philippines Inc. | Philippines | - | - |
Cipla EU Limited | United Kingdom | - | - |
Cipla Brasil Importadora E Distribuidora De Medicamentos Ltda. | Brazil | - | - |
Cipla Australia Pty Limited | Australia | - | - |
Cipla Maroc SA | Morocco | - | - |
Breathe Free Lanka (Private) Limited | Sri Lanka | - | - |
Cipla Malaysia Sdn. Bhd. | Malaysia | - | - |
Cipla Gulf FZ – LLC | United Arab Emirates | - | - |
Cipla Middle East Pharmaceuticals FZ-LLC | United Arab Emirates | - | - |
Cipla Medica Pharmaceutical and Chemical Industries Limited | Yemen | - | - |
Saba Investment Limited | United Arab Emirates | - | - |
Cipla Holding B.V. | Netherlands | - | - |
Cipla Europe NV | Belgium | - | - |
Cipla Algerie | Algeria | - | - |
Meditab Holdings Limited | Mauritius | - | - |
Cipla Quality Chemical Industries Limited | Uganda | - | - |
Cipla Medpro South Africa (Pty) Limited | South Africa | - | - |
CIPLA DIGITAL HEALTH LIMITED | Maharashtra | 2022 | ₹ 30.0 Cr |
CIPLA PHARMACEUTICALS LIMITED | Maharashtra | 2019 | ₹ 72.0 Cr |
CIPLA PHARMA AND LIFE SCIENCES LIMITED | Maharashtra | 2008 | ₹ 258.7 Cr |
CIPLA HEALTH LIMITED | 2015 | ₹ 2.3 Cr | |
SITEC LABS LIMITED | Maharashtra | 2000 | ₹ 1.6 L |
GOLDENCROSS PHARMA LIMITED | Maharashtra | 2000 | ₹ 4.6 L |
MEDISPRAY LABORATORIES PRIVATE LIMITED | Goa | 1992 | ₹ 5.1 L |
MEDITAB SPECIALITIES LIMITED | Maharashtra | 1996 | ₹ 71.2 L |
JAY PRECISION PHARMACEUTICALS PRIVATE LIMITED | Maharashtra | 2012 | ₹ 4.0 Cr |
Actor Pharma (Pty) Limited | South Africa | - | - |
Mexicip S.A. de C.V. | Mexico | - | - |
Read more
The incorporation date of CIPLA LIMITED is 17 August, 1935
The authorized share capital of CIPLA LIMITED is INR ₹ 175.0 Cr.
The paid-up capital of CIPLA LIMITED is INR ₹ 161.5 Cr.
The registered address of CIPLA LIMITED is Cipla House, Peninsula Business Park Ganpatrao Kadam Marg, Lower Parel, Mumbai City, Mumbai, Maharashtra, India, 400013 - 400013
The CIN number of CIPLA LIMITED is L24239MH1935PLC002380.